Minimal Residual Disease Status, Outcomes in Patients with Multiple Myeloma

Tuesday, September 20, 2016 - 04:12 in Health & Medicine

A new study examines the assessment of minimal residual disease in patients newly treated for multiple myeloma as a factor in survival outcomes.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net